Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000819050-20-000170
Filing Date
2020-07-27
Accepted
2020-07-27 08:06:04
Documents
5
Period of Report
2020-07-27
Effectiveness Date
2020-07-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a20200727def-14a.htm DEF 14A 655926
2 image11.jpg GRAPHIC 295292
3 image211.jpg GRAPHIC 136271
4 image311.jpg GRAPHIC 31312
5 image411.jpg GRAPHIC 203830
  Complete submission text file 0000819050-20-000170.txt   1575038
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

EIN.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21088 | Film No.: 201048492
SIC: 2836 Biological Products, (No Diagnostic Substances)